Anvisa libera medicamento injetável que ajuda a reduzir obesidade

from RW saúde – notícias de saúde · host RW Cast

A semaglutida, substância presente no tratamento de Diabetes tipo 2, foi liberada pela Anvisa na segunda-feira (02) para ser utilizada no tratamento da obesidade. Entenda em que circunstância ela deve ser aplicada.

Episode metadata supplied by the publisher feed · Published Jan 3, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Anvisa libera medicamento injetável que ajuda a reduzir obesidade

0:00 1:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RW saúde – notícias de saúde?

This episode is 1 minute long.

When was this RW saúde – notícias de saúde episode published?

This episode was published on January 3, 2023.

Can I download this RW saúde – notícias de saúde episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!